FREE SIGN UP
SIGN IN
ONLINE
ACTIVITIES
Earn CME Credits
LIVE
EVENTS
Webinars/Local Events
CLINICAL
RESOURCES
Reference Materials
  • ONLINE ACTIVITIES
    Earn CME Credits
  • LIVE EVENTS
    Webinars/Local Dates
  • CLINICAL RESOURCES
    Reference Materials
  • FREE SIGN-UP
    Register Now for Access
  • SIGN IN

A Multimedia Activity
linked resources
Suggested Reading

The Big Picture of IBD

An Interactive Experience Highlighting Recent Clinical Advances

Suggested Readings

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.

Colombel JF, et al. Lancet. 2018;390(10114):2779-2789.

Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.

Coskun M, et al. Pharmacol Res. 2013;76:1-8.

Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies.

Kim DH, Cheon JH. Immune Netw. 2017;17(1):25-40.

The future of Janus kinase inhibitors in inflammatory bowel disease.

De Vries LCS, et al. J Crohns Colitis. 2017;11(7):885-893.

JAK inhibition in inflammatory bowel disease.

Olivera P, et al. Expert Rev Clin Immunol. 2017;13(7):693-703.

Tofacitinib as induction and maintenance therapy for ulcerative colitis.

Sandborn WJ, et al. N Engl J Med. 2017;377(5):496-497.

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.

Vermeire S, et al. Lancet. 2017;389(10066):266-275.

Linked Resources

Clinical Practice Guidelines

ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Lichtenstein GR, et al. Am J Gastroenterol. 2018;113(4):481-517.

Ulcerative Colitis Care Pathway.

Dassopoulos T, et al. Gastroenterology. 2015;149(1):238-45.

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Peyrin-Biroulet L, et al. Am J Gastroenterol. 2015;110(9):1324-1338.

European Crohn’s and Colitis Organisation guidelines

References for IBD management in Europe. The guidelines are updated regularly and available for download on the ECCO Website

Maasur C, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications.

J Crohns Colitis. 2018.

Sturm A, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.

J Crohns Colitis. 2018.

Patient Resources

Inflammatory Bowel Disease (IBD): What Is It?

Centers for Disease Control and Prevention (CDC)

Crohn’s and Colitis Foundation

Types of Medications for Crohn's Disease and Ulcerative Colitis

Treatment Decisions: Shared Decision Making

Advocacy Tools and Resources

Crohn’s Disease and Ulcerative Colitis: Emotional Factors Q & A

The National Institute of Diabetes and Digestive and Kidney Diseases Health Information

  • Crohn's Disease

  • Ulcerative Colitis: What Is Ulcerative Colitis?

ExchangeCME is a division of InSci Productions, LLC
Your use of this website constitutes acceptance of InSci Productions, LLC Privacy Policy and Terms of Use. About Us
2023 © InSci Productions, LLC. Material may not be published, broadcast, rewritten, or redistributed in any form without prior authorization.